Back to Search
WILLIAM GRADISHAR, MD
MD
Medical Oncology Physician
NPI: 1437187929IndividualAccepts Medicare
Specialties, Licenses & Credentials
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Class of 1982
Research & Publications (20)
Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer.
PMID 19470941·J Clin Oncol·2009
3-trial
Case records of the Massachusetts General Hospital. Case 30-2008. A 47-year-old woman with a mass in the breast and a solitary lesion in the spine.
PMID 18815400·N Engl J Med·2008
5-case
Albumin-bound paclitaxel: a next-generation taxane.
PMID 16722814·Expert Opin Pharmacother·2006
4-observational
Landmark trials in endocrine adjuvant therapy for breast carcinoma.
PMID 16435388·Cancer·2006
6-review
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.
PMID 16172456·J Clin Oncol·2005
3-trial
Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women.
PMID 16088229·Oncology·2005
6-review
Fulvestrant in the treatment of postmenopausal women with advanced breast cancer.
PMID 16001952·Expert Rev Anticancer Ther·2005
6-review
Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer.
PMID 15905305·Ann Oncol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 675 N SAINT CLAIR ST, GALTER 21-100
CHICAGO, IL 60611 - Phone
- (312) 695-0990
Quick Facts
- NPI
- 1437187929
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile